Kraig Biocraft Laboratories (KBLB) 10-K31 Mar 152014 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2014	Mar. 31, 2015	Jun. 30, 2014
Document And Entity Information
Entity Registrant Name	Kraig Biocraft Laboratories, Inc
Entity Central Index Key	1413119
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$24,396,363
Entity Common Stock, Shares Outstanding		676,903,348
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
ASSETS
Cash	$495,036	$295,381
Prepaid expenses	1,000	1,743
Total Current Assets	496,036	297,124
Property and Equipment, net	43,191	14,093
Total Assets	539,227	311,217
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable and accrued expenses	522,586	427,157
Current portion of loan payable	0	3,981
Royalty agreement payable - related party	64,720	64,720
Accounts payable and accrued expenses - related party	1,177,603	1,016,761
Total Current Liabilities	1,764,909	1,512,619
Commitments and Contingencies
Stockholders' Deficit
Preferred stock Series A, no par value; 2 and 2 shares issued and outstanding, respectively	5,217,800	5,217,800
Common stock Class A, no par value; unlimited shares authorized, 673,974,429 and 635,241,994 shares issued and outstanding, respectively	9,812,845	7,810,920
Common stock Class B, no par value; unlimited shares authorized, no shares issued and outstanding	0	0
Common Stock Issuable, 1,122,311 and 1,122,311 shares, respectively	22,000	22,000
Additional paid-in capital	1,900,018	2,053,236
Accumulated Deficit	-18,178,345	-16,305,358
Total Stockholders' Deficit	-1,225,682	-1,201,402
Total Liabilities and Stockholders' Deficit	$539,227	$311,217

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Stockholders equity:
Preferred stock, par value	$0	$0
Preferred stock, issued shares	2	2
Preferred stock, outstanding shares	2	2
Common stock Class A, par value	$0	$0
Common stock Class A, issued shares	673,974,429	635,241,994
Common stock Class A, outstanding shares	673,974,429	635,241,994
Common stock Class B, par value	$0	$0
Common stock Class B, issued shares	0	0
Common stock Class B, outstanding shares	0	0
Common Stock Issuable, Shares	1,122,311	1,122,311

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended
Statements of Operations (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Revenue	$0	$0
Operating Expenses
General and Administrative	896,079	1,309,923
Professional Fees	180,599	178,373
Officer's Salary	318,144	237,134
Research and Development	439,536	489,434
Total Operating Expenses	1,834,358	2,214,864
Loss from Operations	-1,834,358	-2,214,864
Other Income/(Expenses)
Gain on forgiveness of debt	30,652	6,775
Bad debt expense	0	-6,238
Interest income	0	47
Loss on settlement of accrued payroll - related party	0	-5,187,800
Interest expense	-69,281	-65,605
Total Other Income/(Expenses)	-38,629	-5,252,821
Net (Loss) before Provision for Income Taxes	-1,872,987	-7,467,685
Provision for Income Taxes	0	0
Net (Loss)	($1,872,987)	($7,467,685)
Net Income (Loss) Per Share - Basic and Diluted	$0	($0.01)
Weighted average number of shares outstanding during the period - Basic and Diluted	662,490,382	616,313,968

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended
Statements of Cash Flows (USD $)	Dec. 31, 2014	Dec. 31, 2013
Cash Flows From Operating Activities:
Net Loss	($1,872,987)	($7,467,685)
Adjustments to reconcile net loss to net cash used in operations
Depreciation expense	7,159	5,888
Gain on forgiveness of debt	-30,652	-6,775
Stock issued for services	111,600	0
Loss on settlement of accrued payroll - related party	0	5,187,800
Warrants issued to consultants	574,642	1,132,899
Bad debt expense	0	6,238
Decrease in interest receivable	0	-46
Changes in operating assets and liabilities:
(Increase) Decrease in prepaid expenses	743	527
(Decrease) in accrued expenses and other payables - related party	110,625	223,749
Increase in accounts payable	194,311	117,251
Net Cash Used In Operating Activities	-904,559	-800,154
Cash Flows From Investing Activities:
Purchase of Fixed Assets and Domain Name	-41,805	-3,473
Net Cash Used In Investing Activities	-41,805	-3,473
Cash Flows From Financing Activities:
Proceeds from Notes Payable - Stockholder	0	150,000
Repayments of Notes Payable - Stockholder	0	-150,000
Repayment of loan payable	-3,981	-4,774
Proceeds from issuance of common stock	1,150,000	1,050,000
Net Cash Provided by Financing Activities	1,146,019	1,045,226
Net Increase (Decrease) in Cash	199,655	241,599
Cash at Beginning of Period	295,381	53,782
Cash at End of Period	495,036	295,381
Supplemental disclosure of cash flow information:
Cash paid for interest	0	0
Cash paid for taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Shares issued in connection with cashless warrants exercise	736,816	400,000
Shares issued for settlement of accrued payroll - related party	0	30,000
Settlement of accounts payable with stock issuance	3,509	0
Gain on the sale of the fixed asset to a related party	8,956	0
Fixed asset sold to related party to cancel accounts payable - related party	$5,548	$0

Statement_of_Changes_in_Stockh

Statement of Changes in Stockholders Deficit (USD $)	Preferred Stock - Series A	Common Stock - Class A	Common Stock - Class B	Common Stock - Class A Shares	APIC	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2012		$6,360,920		$22,000	$1,320,337	($8,837,673)	($1,134,416)
Beginning Balance, Shares at Dec. 31, 2012		604,115,638		1,122,311
Make up shares issued for the transaction entered during the December 31, 2012 year end
Stock issued for cash ($0.05/share), Shares		961,538
Stock issued for cash ($0.05/share), Amount		50,000					50,000
Stock issued for cash ($0.05/share), Shares		945,537
Stock issued for cash ($0.05/share), Amount		50,000					50,000
Stock issued for cash ($0.06/share), Shares		822,368
Stock issued for cash ($0.06/share), Amount		50,000					50,000
Stock issued for cash ($0.08/share), Shares		884,434
Stock issued for cash ($0.08/share), Amount		75,000					75,000
Stock issued for cash ($0.06/share), Shares		3,521,126
Stock issued for cash ($0.06/share), Amount		200,000					200,000
Stock issued for cash ($0.05/share), Shares		1,838,235
Stock issued for cash ($0.05/share), Amount		100,000					100,000
Stock issued for cash ($0.05/share), Shares		1,923,077
Stock issued for cash ($0.05/share), Amount		100,000					100,000
Stock issued for cash ($0.05/share), Shares		2,100,840
Stock issued for cash ($0.05/share), Amount		100,000					100,000
Stock issued for cash ($0.04/share), Shares		5,208,334
Stock issued for cash ($0.04/share), Amount		200,000					200,000
Stock issued for cash ($0.04/share), Shares		3,063,725
Stock issued for cash ($0.04/share), Amount		125,000					125,000
Preferred Stock issued, Shares	2
Preferred Stock issued, Amount	5,217,800						5,217,800
Exercise of warrants in exchange for stock, Shares		9,857,142
Exercise of warrants in exchange for stock, Amount		400,000			-400,000
Grant warrants for services					736,816		736,816
Grant 8,000,000 warrants for services, net of M2M adjustment for unvested warrants					396,083		396,083
Gain on the sale of the fixed asset to a related party							0
Net Loss						-7,467,685	-7,467,685
Ending Balance, Amount at Dec. 31, 2013	5,217,800	7,810,920		22,000	2,053,236	-16,305,358	-1,201,402
Ending Balance, Shares at Dec. 31, 2013	2	635,241,994		1,122,311
Stock issued for cash ($0.04/share), Shares		27,051,006
Stock issued for cash ($0.04/share), Amount		1,150,000					1,150,000
Exercise of warrants in exchange for stock, Shares		9,821,429
Exercise of warrants in exchange for stock, Amount		736,816			-736,816
Grant warrants for services					574,642		574,642
Settlement of accounts payable with stock issuance, Shares		60,000
Settlement of accounts payable with stock issuance, Amount		3,509					3,509
Shares issued for services ($0.062/share), Shares		1,800,000
Shares issued for services ($0.062/share), Amount		111,600					111,600
Gain on the sale of the fixed asset to a related party					8,956		8,956
Net Loss						-1,872,987	-1,872,987
Ending Balance, Amount at Dec. 31, 2014	$5,217,800	$9,812,845		$22,000	$1,900,018	($18,178,345)	($1,225,682)
Ending Balance, Shares at Dec. 31, 2014	2	673,974,429		1,122,311

Statement_of_Changes_in_Stockh1

Statement of Changes in Stockholders Deficit (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Number of common stock exercised	10,000,000	10,000,000
Number of warrants granted	10,200,000	10,000,000
Transaction One
Stock issued for cash, price per share	0.04	0.05
Transaction Two
Stock issued for cash, price per share		0.05
Transaction Three
Stock issued for cash, price per share		0.06
Transaction Four
Stock issued for cash, price per share		0.08
Transaction Five
Stock issued for cash, price per share		0.06
Transaction Six
Stock issued for cash, price per share		0.05
Transaction Seven
Stock issued for cash, price per share		0.05
Transaction Eight
Stock issued for cash, price per share		0.05
Transaction Nine
Stock issued for cash, price per share		0.04
Transaction Ten
Stock issued for cash, price per share		0.04
M2M adjustment
Number of warrants granted		8,000,000

1_SUMMARY_OF_SIGNIFICANT_ACCOU

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	(A) Organization

	Kraig Biocraft Laboratories, Inc. (the "Company") was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries.

	(B) Use of Estimates

	In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.

	(C) Cash

	For purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of December 31, 2014 or December 31, 2013.

	(D) Loss Per Share

	Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by FASB Accounting Standards Codification No. 260, “Earnings per Share.” As of December 31, 2014 and 2013, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive.

	The computation of basic and diluted loss per share at December 31, 2014 and December 31, 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

			December 31,			December 31,
			2014			2013

	Stock Warrants (Exercise price - $0.001/share)			18,000,000			18,000,000
	Convertible Preferred Stock			2			2
	Total			18,000,002			18,000,002

	(E) Research and Development Costs

	The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation.

	(F) Income Taxes

	The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

	The net deferred tax liability in the accompanying balance sheets includes the following amounts of deferred tax assets and liabilities:

				2014			2013

	Expected income tax recovery (expense) at the statutory rate of 34%		$	-636,816		$	(2,539,012)
	Tax effect of expenses that are not deductible for income tax purposes (net of other amounts deductible for tax purposes)			222,901			2,153,127
	Change in valuation allowance			413,915			385,583

	Provision for income taxes		$	-		$	-

	The components of deferred income taxes are as follows:

				Years Ended December,
				2014			2013

	Deferred tax liability:		$	-		$	-
	Deferred tax asset
	Net Operating Loss Carryforward			2,829,510			2,415,595
	Valuation allowance			-2,829,510			-2,415,595
	Net deferred tax asset			-			-
	Net deferred tax liability		$	-		$	-

	The valuation allowance was established to reduce the deferred tax asset to the amount that will more likely than not be realized. This is necessary due to the Company’s continued operating losses and the uncertainty of the Company’s ability to utilize all of the net operating loss carryforwards before they will expire through the year 2034.

	The net change in the valuation allowance for the year ended December 31, 2014 and 2013 was an increase of $413,915 and $385,853, respectively.

	Effective January 1, 2009, the Company adopted guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the financial statements and applies to all federal or state income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. As of December 31, 2014 and 2013 there were no amounts that had been accrued in respect to uncertain tax positions.

	None of the Company’s federal or state income tax returns is currently under examination by the Internal Revenue Service (“IRS”) or state authorities. However, fiscal years 2009 and later remain subject to examination by the IRS and respective states.

	(G) Derivative Financial Instruments

Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.

Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. In addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model.

(H) Stock-Based Compensation

In December 2004, the FASB issued FASB Accounting Standards Codification No. 718, Compensation – Stock Compensation. Under FASB Accounting Standards Codification No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant. The Company applies this statement prospectively.

Equity instruments (“instruments”) issued to other than employees are recorded on the basis of the fair value of the instruments, as required by FASB Accounting Standards Codification No. 718. FASB Accounting Standards Codification No. 505, Equity Based Payments to Non-Employees defines the measurement date and recognition period for such instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.

(I) Business Segments

The Company operates in one segment and therefore segment information is not presented.

(J) Recent Accounting Pronouncements

On November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-16—Derivatives and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity (a consensus of the FASB Emerging Issues Task Force). The amendments in this Update do not change the current criteria in GAAP for determining when separation of certain embedded derivative features in a hybrid financial instrument is required. That is, an entity will continue to evaluate whether the economic characteristics and risks of the embedded derivative feature are clearly and closely related to those of the host contract, among other relevant criteria. The amendments clarify how current GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. The effects of initially adopting the amendments in this Update should be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of a share as of the beginning of the fiscal year for which the amendments are effective. Retrospective application is permitted to all relevant prior periods.

On November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-17—Business Combinations (Topic 805): Pushdown Accounting (a consensus of the FASB Emerging Issues Task Force). The amendments in this Update provide an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. The amendments in this Update are effective on November 18, 2014. After the effective date, an acquired entity can make an election to apply the guidance to future change-in-control events or to its most recent change-in-control event. However, if the financial statements for the period in which the most recent change-in-control event occurred already have been issued

On June 10, 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation ("ASUE 2014-10"). The guidance is intended to reduce the overall cost and complexity associated with financial reporting for development stage entities without reducing the availability of relevant information. The Board also believes the changes will simplify the consolidation accounting guidance by removing the differential accounting requirements for development stage entities. As a result of these changes, there no longer will be any accounting or reporting differences in GAAP between development stage entities and other operating entities. For organizations defined as public business entities the presentation and disclosure requirements in Topic 915 will no longer be required starting with the first annual period beginning after December 15, 2014, including interim periods therein. Early application is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued (public business entities) or made available for issuance (other entities). The Company adopted this pronouncement for the period from April 25, 2006 (inception) through December 31, 2014.

In June 2014, FASB issued Accounting Standards Update (“ASU”) No. 2014-12, “Compensation – Stock Compensation (Topic 718); Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period”. The amendments in this ASU apply to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. For all entities, the amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. Entities may apply the amendments in this ASU either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. If retrospective transition is adopted, the cumulative effect of applying this Update as of the beginning of the earliest annual period presented in the financial statements should be recognized as an adjustment to the opening retained earnings balance at that date. Additionally, if retrospective transition is adopted, an entity may use hindsight in measuring and recognizing the compensation cost. This updated guidance is not expected to have a material impact on our results of operations, cash flows or financial condition. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition

On August 2014, the FASB issued Accounting Standards Update “ASU” 2014-15 on “Presentation of Financial Statements Going Concern (Subtopic 205-40) - Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this Update provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this Update are effective for public and nonpublic entities for annual periods ending after December 15, 2016. Early adoption is permitted. As of December 31, 2014, we have adopted the provisions of this ASU.

In July 2013, FASB issued ASU No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists." The provisions of ASU No. 2013-11 require an entity to present an unrecognized tax benefit, or portion thereof, in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward, with certain exceptions related to availability. ASU No. 2013-11 is effective for interim and annual reporting periods beginning after December 15, 2013. The adoption of ASU No. 2013-11 is not expected to have a material impact on the Company's Consolidated Financial Statements.

In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into net income. The amendments in the ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial statements under U.S. GAAP. The new amendments will require an organization to:

-	Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and
-	Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.

The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). The amendments are effective for reporting periods beginning after December 15, 2012, for public companies. Early adoption is permitted. The adoption of ASU No. 2013-02 is not expected to have a material impact on our financial position or results of operations.

In January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like ASU 2011-11, the amendments in this update will be effective for fiscal periods beginning on, or after January 1, 2013. The adoption of ASU 2013-01 is not expected to have a material impact on our financial position or results of operations.

All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable

(K) Reclassification

The 2013 financial statements have been reclassified to conform to the 2014 presentation.

*(L) Equipment*

The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. The Company uses a five year life for automobiles.

In accordance with FASB Accounting Standards Codification No. 360, Property, Plant and Equipment, the Company carries long-lived assets at the lower of the carrying amount or fair value. Impairment is evaluated by estimating future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected undiscounted future cash flow is less than the carrying amount of the assets, an impairment loss is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.

There were no impairment losses recorded during the years ended December 31, 2014 and 2013.

(M) Fair Value of Financial Instruments

We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” (“ASC Topic 820-10”). ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Level 1 instruments include cash, account receivable, prepaid expenses, inventory and account payable and accrued liabilities. The carrying values are assumed to approximate the fair value due to the short term nature of the instrument.

The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:

°	Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at December 31, 2014 and December 31, 2013.

°	Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

°	Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms.

		December 31,			December 31,
		2014			2013
Level 1		$	-		$	-
Level 2			-			-
Level 3			-			-
Total		$	-		$	-

2_GOING_CONCERN

2. GOING CONCERN	12 Months Ended
2. GOING CONCERN	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	As reflected in the accompanying financial statements, the Company has a working capital deficiency of 1,268,873 and stockholders’ deficiency of $1,225,682 and used $904,559 of cash in operations for the year ended December 31, 2014. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

	Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

3_EQUIPMENT

3. EQUIPMENT	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
EQUIPMENT
	At December 31, 2014 and December 31, 2013 equipment is as follows:

		As of			As of
		December 31,			December 31,
		2014			2013

	Automobile	$	41,805		$	25,828
	Office Equipment		5,560			5,560
	Less Accumulated Depreciation		(4,174	)		(17,295	)

	Total Property and Equipment	$	43,191		$	14,093

	Depreciation and amortization expense for the years ended December 31, 2014 and 2013 was $7,159 and $5,888, respectively.

	On November 10, 2014, the Company sold to the officer of the Company a used automobile for the price of $14,504. The Company recorded a gain on the sale of the asset of $8,956 as donated capital due to the transaction being with a related party.

4_LOAN_PAYABLE

4. LOAN PAYABLE	12 Months Ended
4. LOAN PAYABLE	Dec. 31, 2014
Debt Disclosure [Abstract]
LOAN PAYABLE	On December 8, 2010 the Company entered into a five year loan agreement with the principal loan amount of $15,828. The loan carries an interest rate of 6.94%, and is secured by an automobile. For the years ending December 31, 2014 and December 31, 2013, the Company repaid $3,981, and $4,774 in loan balance, respectively. At December 31, 2014 the loan balance was repaid in full.

5_LOAN_PAYABLERELATED_PARTY

5. LOAN PAYABLE-RELATED PARTY	12 Months Ended
5. LOAN PAYABLE-RELATED PARTY	Dec. 31, 2014
Related Party Transactions [Abstract]
LOAN PAYABLE-RELATED PARTY	On February 25, 2013 the Company received $150,000 from a principal stockholder. Pursuant to the terms of the loan, the advance bears interest at 3%, is unsecured and due on demand. At December 31, 2013 the loan balance was repaid. The Company recorded accrued interest payable of $2,001.

6_STOCKHOLDERS_DEFICIT

6. STOCKHOLDERS' DEFICIT	12 Months Ended
6. STOCKHOLDERS' DEFICIT	Dec. 31, 2014
Equity [Abstract]
STOCKHOLDERS' DEFICIT	(A) Common Stock Issued for Cash

	On February 19, 2013, the Company issued 961,538 shares of common stock for $50,000 ($0.05/share).

	On March 4, 2013, the Company issued 945,537 shares of common stock for $50,000 ($0.05/share).

	On April 1, 2013, the Company issued 822,368 shares of common stock for $50,000 ($0.06/share).

	On April 15, 2013, the Company issued 884,434 shares of common stock for $75,000 ($0.08/share).

	On July 11, 2013 the Company issued 1,760,563 shares of common stock for $100,000 ($0.06/share).

	On July 25, 2013 the Company issued 1,760,563 shares of common stock for $100,000 ($0.06/share).

	On August 13, 2013 the Company issued 1,838,235 shares of common stock for $100,000 ($0.05/share).

	On September 3, 2013 the Company issued 1,923,077 shares of common stock for $100,000 ($0.05/share).

	On September 19, 2013 the Company issued 2,100,840 shares of common stock for $100,000 ($0.05/share).

	On October 3, 2013 the Company issued 2,604,167 shares of common stock for $100,000 ($0.04/share).

	On October 17, 2013 the Company issued 2,604,167 shares of common stock for $100,000 ($0.04/share).

	On December 11, 2013 the Company issued 3,063,725 shares of common stock for $125,000 ($0.04/share).

	On January 28, 2014 the Company issued 3,537,736 shares of common stock for $150,000 ($0.04/share).

	On February 18, 2014 the Company issued 3,409,091 shares of common stock for $150,000 ($0.04/share).

	On March 12, 2014 the Company issued 2,551,020 shares of common stock for $100,000 ($0.04/share).

	On April 7, 2014 the Company issued 2,212,389 shares of common stock for $100,000 ($0.05/share).

	On April 22, 2014 the Company issued 2,173,913 shares of common stock for $100,000 ($0.05/share).

	On June 10, 2014 the Company issued 3,409,091 shares of common stock for $150,000 ($0.04/share).

	On July 7, 2014, the Company issued 2,212,389 share of common stock for $100,000 ($0.05/share).

	On August 6, 2014, the Company issued 2,272,727 share of common stock for $100,000 ($0.04/share).

	On September 3, 2014, the Company issued 2,450,980 share of common stock for $100,000 ($0.04/share).

	On September 22, 2014, the Company issued 2,821,670 share of common stock for $100,000 ($0.04/share).

	(B) Common Stock Issued for Services

	Shares issued for services as mentioned below were valued at the closing price of the stock on the date of grant.

	On March 28, 2014, the Company issued 44,000 shares of common stock with a fair value of $2,864 ($0.065/share) to a consultant as consideration for consulting fees owed from June 1, 2012 through March 31, 2014 of $44,000. The issuance of shares resulted in gain on settlement of accounts payable of $19,136.

	On April 23, 2014, the Company issued 1,800,000 shares of common stock with a fair value of $111,600 ($0.062/share) to a consultant as consideration for consulting services.

	On October 9, 2014 the Company issued 12,000 shares with a fair value of $484 ($0.0403/share) to a consultant as consideration for consulting fees owed from April 1, 2014 through September 30, 2014 of $12,000. The consultant also received a bonus of 4,000 shares with a fair value of $161 ($0.0403/share). The issuance of shares resulted in gain on settlement of accounts payable of $11,516.

	(C) Common Stock Warrants

	On February 2, 2014, the Company issued 9,821,429 shares in connection with the cashless exercise of 10,000,000 shares of warrants.

	On November 21, 2012, the Company issued 10-year warrants for 10,000,000 shares with a consultant, with an exercise price of $0.001 per share. The warrants were granted for services rendered. The warrants had a fair value of $400,000, based upon the Black-Scholes option-pricing model. The Company used the following weighted average assumptions:

	Expected dividends			0	%
	Expected volatility			283.23	%
Expected term		10 years
Risk free interest rate			1.69	%
Expected forfeitures			0	%

On July 18, 2013, the Company issued 9,857,142 shares in connection with the cashless exercise of the 10,000,000 warrants.

On July 9, 2013, the Company issued 5-year warrants for 10,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services rendered. The warrants had a fair value of $736,816, based upon the Black-Scholes option-pricing model. The Company used the following weighted average assumptions:

Expected dividends			0	%
Expected volatility			183.35	%
Expected term		5 years
Risk free interest rate			1.5	%
Expected forfeitures			0	%

On October 15, 2013, the Company issued 1-year warrants for 8,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $396,083, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon and will be exercisable beginning October 15, 2015 for a period of 12 months.

		Grant Date
Expected dividends			0	%
Expected volatility			96.35	%

Expected term		3 years
Risk free interest rate			1.45	%
Expected forfeitures			0	%

On February 17, 2014, the Company issued 1-year warrants for 600,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $33,620, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon and will be exercisable beginning on the 14 th month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			86.94	%

Expected term		2 years
Risk free interest rate			1.53	%
Expected forfeitures			0	%

On February 17, 2014, the Company issued 1-year warrants for 600,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $33,620, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 14 th month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			86.94	%

Expected term		2 years
Risk free interest rate			1.53	%


On February 17, 2014, the Company issued 1-year warrants for 1,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $56,040, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 20 th month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			86.23	%

Expected term		3 years
Risk free interest rate			1.53	%
Expected forfeitures			0	%

On February 17, 2014, the Company issued 1-year warrants for 1,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $56,040, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 20 th month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			86.23	%

Expected term		3 years
Risk free interest rate			1.53	%
Expected forfeitures			0	%

On February 17, 2014, the Company issued 1-year warrants for 2,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $112,110, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 32nd month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			123.49	%

Expected term		3 years
Risk free interest rate			1.53	%
Expected forfeitures			0	%

On February 17, 2014, the Company issued 1-year warrants for 2,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $112,110, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 32nd month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			123.49	%

Expected term		3 years
Risk free interest rate			1.53	%
Expected forfeitures			0	%

On June 4, 2014, the Company issued 3-year warrant for 3,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $171,102, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 32nd month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			86.69	%

Expected term		3 years
Risk free interest rate			0.85	%
Expected forfeitures			0	%

		Number of				Weighted Average Exercise Price				Weighted Average Remaining Contractual Life
		Warrants								(in Years)




Balance, December 31, 2013			18,000,000			$	0.001			2.9
Granted			10,200,000			$	0.001
Exercised			(10,000,000	)		$	-
Cancelled/Forfeited			-
Balance, September 30, 2014December 31, 2014			18,200,000			$	0.001				2.1

Intrinsic Value		$	801,900


For the year ended December 31, 2014, the following warrants were outstanding:

Exercise Price				Warrants				Warrants				Weighted Average		Aggregate
Exercise Price				Outstanding				Exercisable				Remaining Contractual Life		Intrinsic Value

$	0.001				18,200,000				-				2.1		801,900


For the year ended December 31, 2013, the following warrants were outstanding:

Exercise Price				Warrants				Warrants				Weighted Average		Aggregate
Exercise Price				Outstanding				Exercisable				Remaining Contractual Life		Intrinsic Value

$	0.001				28,000,000				18,000,000				2.9		918,000


(D) Amendment to Articles of Incorporation

On February 16, 2009, the Company amended its articles of incorporation to amend the number and class of shares the Company is authorized to issue as follows:

●	Common stock Class A, unlimited number of shares authorized, no par value
●	Common stock Class B, unlimited number of shares authorized, no par value
●	Preferred stock, unlimited number of shares authorized, no par value

Effective December 17 2013, the Company amended its articles of incorporation to designate a Series A no par value preferred stock. Two shares of Series A Preferred stock have been authorized.

(E) Conversion of debt & Issuance of Convertible Preferred Stock – related party

During the year ended December 31, 2013, the Company's Chief Executive Officer converted accrued payroll of $30,000 in exchange for the issuance of Series A convertible Preferred Stock (“Series A PS”).

Each share of Series A PS is entitled to vote together with the holders of the Company’s common stock on all matters and is entitled to 200,000,000 votes on all such matters. Each Share of Series A PS is convertible into one share of the Company’s common stock at the holder’s option.

		Series A
		PS Valuation
Debt converted – related party		$	(30,000	)
Valuation of Series A PS issued as consideration			5,217,800
Loss on settlement of debt		$	5,187,800

The valuation of the Series A PS was performed by a third party valuation expert and was based on the voting control obtained and the Company's market cap at the time of the transaction.

7_COMMITMENTS_AND_CONTINGENCIE

7. COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	On March 18, 2010, the Company entered into an addendum to the employment agreement whereby the Company will reimburse the employee and his family for up to $20,000 of out of pocket medical and dental care costs, including prescription costs or co-pays.

	On September 30, 2010, the Company entered into an addendum to the employment agreement whereby all but $250,000 of unpaid back salary will be forgiven by the principal stockholder. The addendum also eliminated the various milestone achievement awards from the prior employment agreements. In addition, the addendum reduced the interest rate to 3% per year. Further, the conversion rights for unpaid back salary where amended whereby the principal shareholder has the option to convert any accrued salary into Class “A” Common stock by dividing the dollar value of the debt to be converted to stock by the closing price of the stock on the date that the conversion notice is received by the Company. This amendment effectively eliminated any beneficial conversion features related to accrued salary of September 30, 2010. In exchange the Company agreed to issue 10,000,000 preferred shares to the principal stockholder no later than September 30, 2011, that date was extended by mutual agreement to December 31, 2012. The agreement was subsequently extended to October 30, 2013. By agreement with the principal shareholder, this obligation to issue preferred shares was satisfied by the December 17, 2013 issuance of 2 shares of super voting preferred stock.

	On November 10, 2010, the Company entered into an addendum to the employment agreement, effective January 1, 2011 through the December 31, 2015. The term of the agreement is a five year period at an annual salary of $210,000. There is a 6% annual increase. For the year ending December 31, 2014 the annual salary is $265,120. The employee is also to receive a 20% bonus based on the annual based salary. Any stock, stock options bonuses have to be approved by the board of directors (See Note 8).

	On October 2, 2014, the Company entered into a letter agreement for an equity line of financing up to $7,500,000 (the “Letter Agreement”) with Calm Seas Capital, LLC (“Calm Seas”).

	Under the Letter Agreement, over a 24 month period from the Effective Date (as defined below) we may put to Calm Seas up to an aggregate of $7,500,000 in shares of our Class A common stock for a purchase price equal to 80% of the lowest price of our Class A common stock during the five consecutive trading days immediately following the date we deliver notice to Calm Seas of our election to put shares pursuant to the Letter Agreement. We may put shares bi-monthly. The dollar value that will be permitted for each put pursuant to the Letter Agreement will be the lesser of: (A) the product of (i) 200% of the average daily volume in the US market of our Class A common stock for the ten trading days prior to the date we deliver our put notice to Calm Seas multiplied by (ii) the average of the daily closing prices for the ten (10) trading days immediately preceding the date we deliver our put notice to Calm Seas, or (B) $100,000. We will automatically withdraw our put notice to Calm Seas if the lowest closing bid price used to determine the purchase price of the put shares is not at least equal to seventy-five percent (75%) of the average closing “bid” price for our Class A common stock for the ten (10) trading days prior to the date we deliver our put notice to Calm Seas. Notwithstanding the $100,000 ceiling for each bi-monthly put, as described above, we may at any time request Calm Seas to purchase shares in excess of such ceiling, either as a part of bi-monthly puts or as an additional put(s) during such month. If Calm Seas, in its sole discretion, accepts such request to purchase additional shares, then we may include the put for additional shares in our monthly put request or submit an additional put for such additional shares in accordance with the procedure set forth above.

	The Letter Agreement will terminate when any of the following events occur:

	●	Calm Seas has purchased an aggregate of $7,500,000 of our Class A common stock; or

	●	The second anniversary from the Effective Date.

	(A)License Agreement

	On May 8, 2006, the Company entered into a license agreement. Pursuant to the terms of the agreement, the Company paid a non-refundable license fee of $10,000. The Company will pay a license maintenance fee of $10,000 on the one year anniversary of this agreement and each year thereafter. The Company will pay an annual research fee of $13,700 with first payment due January 2007, then on each subsequent anniversary of the effective date commencing May 4, 2007. Pursuant to the terms of the agreement the Company may be required to pay additional fees aggregating up to a maximum of $10,000 a year for patent maintenance and prosecution relating to the licensed intellectual property.

	On October 28, 2011, the Company entered into a license agreement with the University of Notre Dame. Under the agreement, the Company received exclusive and non-exclusive rights to certain spider silk technologies including commercial rights with the right to sublicense such intellectual property. In consideration of the licenses granted under the agreement, the Company agreed to issue to the University of Notre Dame 2,200,000 shares of its common stock and to pay a royalty of 2% of net sales. In addition, the Company is in negotiations with the University of Notre Dame for a research and development agreement. On March 4, 2015, the Company entered into a new Intellectual Property / Collaborative Research Agreement with Notre Dame extending the duration of the agreement through March 2016. Under the agreement the Company will provide approximately $534,000 in financial support. The license agreement has a term of 20 years which can be extended on an annual basis after that. It can be terminated by the University of Notre Dame if the Company defaults on its obligations under the agreement and fails to cure such default within 90 days of a written notice by the university. The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years.

	(B)Royalty and Research Agreements

	On May 1, 2008 the Company entered into a five year consulting agreement for research and development. Pursuant to the terms of the agreement, the Company will be required to pay $1,000 per month, or at the Company’s option, the consulting fee may be paid in the form of Company common stock based upon the greater of $0.05 per share or the average of the closing price of the Company’s shares over the five days preceding such stock issuance. As of June 30, 2011 the Company had accrued $17,000 of accounts payable for the services provided of which was paid in common stock on July 1, 2009 (See Note 6(C)). As of June 30, 2011 the Company issued 280,000 shares of common stock in exchange for $14,000 of accounts payable for the services performed. On March 19, 2014, the Company entered into a five year consulting agreement for general advisor and consulting services. As consideration for the services performed, the Company agrees to pay the consultant a fee of $1,000 per month. At the Company’s option, said consulting fee may be paid to the consultant in the form of Company stock based upon the greater of $0.50/share or the average of the closing price of the Company’s common stock over the five days preceding such stock issuance. On March 28, 2014, issue 44,000 shares of common stock as consideration for consulting fees owed from June 1, 2012 through March 31, 2014. On October 9, 2014 the Company issued 12,000 shares with a fair value of $484 ($0.0403/share) to a consultant as consideration for consulting fees owed from April 1, 2014 through September 30, 2014 of $12,000. The issuance of shares resulted in gain on settlement of accounts payable of $11,516. The consultant also received a bonus of 4,000 shares with a fair value of $161 ($0.0403/share).

	On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with an officer. In consideration of the Company issuing either 200,000 preferred shares with the following preferences; no dividends and voting rights equal to 100 common shares per share of preferred stock or the payment of $120,000, the officer agreed to terminate the royalty payments due under the agreement and give title to the exclusive license for the non-protective apparel use of the intellectual property to the Company. On the date of the agreement, the Company did not have any preferred stock authorized with the required preferences. In accordance with FASB Accounting Standards Codification No 480, Distinguishing Liabilities from Equity, the Company determined that the present value of the payment of $120,000 that was due on December 26, 2007, the one year anniversary of the addendum, should be recorded as an accrued expense until such time as the Company has the ability to assert that it has preferred shares authorized. As of March 31, 2010, the Company has recorded $120,000 in accrued expenses- related party. On December 21, 2007 the officer extended the due date to July 30, 2008. On May 30, 2008 the officer extended the due date to December 31, 2008. On October 10, 2008, the officer extended the due date to the earlier of (a) March 30, 2010 or (b) upon demand by the officer. The due date was extended to March 31, 2011. On September 8, 2009, a payment of $15,000 was paid to the officer. An additional payment of $10,000 was made on October 19, 2009 and December 1, 2009, respectfully. Additionally, the accrued expenses are accruing 7% interest per year. On January 15, 2010 an additional payment of $10,000 was made. During the quarter ending September 30, 2010 an additional payment of $8,000 was made. During the quarter ending September 30, 2012 an additional payment of $1,000 was made. During the year ended December 31, 2013, an additional payment of $1,280 was made. During the year ended December 31, 2014, an additional loan of $572 was made. As of December 31, 2014 the outstanding balance is $65,292. As of December 31, 2014 the Company recorded interest expense and related accrued interest payable of $1,954.

	On June 6, 2012 the Company entered into a consulting agreement for intellectual property and collaborative research and development with an American university. The agreement covers ongoing research and development work performed by the university at the Company’s behest and with the Company’s assistance. On March 4, 2015, the Company entered into a new Intellectual Property / Collaborative Research Agreement with Notre Dame extending the duration of the agreement through March 2016. Pursuant to the terms of the agreement the Company will be required to pay approximately $534,000 for research and development over the two year period. For the year ended December 31, 2014 and 2013, respectively, the company paid $439,536 and $489,434 in research and development fees.

	(C)Consulting Agreement

	On July 9, 2013, the Company entered into an agreement with a consultant to provide investor relations services in exchange for a warrant for 10,000,000 common shares at $.001 with a cashless provision and a five year term.

	On September 30, 2013 the Company entered into a Collaborative Yarn and Textile Development Agreement with a technical textile manufacturing company. Pursuant to the terms of that agreement the Company has agreed to supply the technical textile manufacturing company with sample quantities of the Company’s recombinant spider silk for the purpose of developing and testing new textiles which are made from, or which incorporate recombinant spider silk. The agreement provides that the two companies will jointly share, on an equal basis, any intellectual property, including any utility patents, which are developed as a result of this collaboration. Such intellectual property potentially includes utility patents on textile designs. The Company has agreed that it will pay half of the cost associated with the filing and prosecution of utility patents relating to intellectual property which is developed through its collaboration with the technical textile manufacturing company.

	On October 15, 2013 the Company entered into an intellectual property agreement with a scientific researcher relating to the development of new recombinant silk fibers. Under the terms of that agreement the scientific researcher will transfer to the Company his rights to intellectual property, inventions and trade secrets which the researcher develops relating to recombinant silk. The researcher will receive 8,000,000 warrants of the Company’s stock, exercisable 24 months from the date of the agreement. The researcher will also receive additional warrants when and if the researcher develops advanced recombinant silk fibers for the Company’s use. Under the terms of the agreement the researcher will receive 10,000,000 warrants in the event that he develops a new recombinant silk fiber with certain performance characteristics, and another 10,000,000 warrants if he develops a second recombinant silk fiber with certain characteristics. If the consultant performs the contract in good faith the consultant will be entitled to an additional 8,000 warrants. The warrants described in this note all contain a cashless exercise provision and are exercisable on the 24 month anniversary of the date on which they were issuable under the agreement.

	On February 17, 2014, the Company entered into two consulting agreements with two consultants for independent technical expertise to further the Company’s business plans and scientific research and development. As consideration for the services performed, the Company agrees to issue the following to each of the consultants:

	●	Within 30 days of the date of this agreement, a warrant for six hundred thousand shares of the Company’s common stock to be exercisable on the 14 month anniversary of this agreement for a period of 12 months with a cashless exercise provision.

	●	Within 30 days of the date of this agreement, a warrant for one million shares of the Company’s common stock to be exercisable on the 20 month anniversary of this agreement for a period of 12 months with a cashless exercise provision.

	●	Within 30 days of the date of this agreement, a warrant for two million shares of the Company’s common stock to be exercisable on the 32 month anniversary of this agreement for a period of 12 months with a cashless exercise provision.

	●	Based on the consultants reaching two sets of benchmarks, two separate warrants for one million five hundred thousand shares of the Company’s common stock to be exercisable on the 28 month anniversary of this agreement for a period of 12 months with a cashless exercise provision.

	●	On the three year anniversary, assuming the consultant acted in good faith and the Company’s board of directors approval, a warrant for one million five hundred thousand shares of the Company’s common stock to be exercisable on the 28 month anniversary of this agreement for a period of 12 months with a cashless exercise provision.

	On April 23, 2014, the Company entered into a six months agreement with a consultant to provide investor relations services. As consideration for the services performed, the Company agrees to issue 1,800,000 shares of common stock. On May 5, 2014, the company issued 1,800,000 shares of common stock for $111,600 ($0.062/share).

	On April 30, 2014 the Company entered into a one year agreement with a consultant for research and development. As consideration for services, the Company agrees to pay for Consultant’s air fare from the United States to Africa, for a trip scheduled in early May 2014.

	On June 4, 2014 the Company entered into a one year agreement with a consultant to provide investor relations services. As consideration for the services performed, the Company agrees to issue a warrant for 3,000,000 shares of common stock $0.001 with a cashless exercise provision and a three year term. On June 24, 2014, the company issued a warrant for 3,000,000 shares of common stock with a fair value of $171,102 (See Note 6(E)).

	(D) Operating Lease Agreement

	On April 1, 2012 the Company executed a one-year non-cancelable operating lease for its Laboratory space. The lease was subsequently extended through March 31, 2014. In March of 2014, the Company once again extended the lease on a month to month basis.

	On March 21, 2014, the Company renewed its lease of a Laboratory. The lease is on a month to month basis at an annual rate of $12,750.

	Rent expense for the years ended December 31, 2014 and 2013 is $14,137 and $13,565, respectively.

8_RELATED_PARTY_TRANSACTIONS

8. RELATED PARTY TRANSACTIONS	12 Months Ended
8. RELATED PARTY TRANSACTIONS	Dec. 31, 2014
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with an officer. In consideration of the Company issuing either 200,000 preferred shares with the following preferences; no dividends and voting rights equal to 100 common shares per share of preferred stock or the payment of $120,000, the officer agreed to terminate the royalty payments due under the agreement and give title to the exclusive license for the non-protective apparel use of the intellectual property to the Company. On the date of the agreement, the Company did not have any preferred stock authorized with the required preferences. In accordance with In accordance with FASB Accounting Standards Codification No. 480, Distinguishing Liabilities from Equity, the Company determined that the present value of the payment of $120,000 that was due on December 26, 2007, the one year anniversary of the addendum, should be recorded as an accrued expense until such time as the Company has the ability to assert that it has preferred shares authorized. As of March 31, 2010, the Company has recorded $120,000 in royalty agreement payable- related party. On December 21, 2007 the officer extended the due date to July 30, 2008. On May 30, 2008 the officer extended the due date to March 31, 2009. On October 10, 2008, the officer extended the due date to the earlier of (a) March 30, 2010 or (b) upon demand by the officer. On March 30, 2010, the officer extended the due date to the earlier of (a) March 30, 2010 or (b) upon demand by the officer. On September 8, 2009, a payment of $15,000 was paid to the officer. On October 19, 2009 and December 1, 2009, $10,000 was paid to the officer respectfully. An additional payment of $10,000 was made on January 15, 2010. During the quarter ending September 30, 2010 an additional payment of $8,000 was made. During the year ended December 31, 2012 an additional payment of $1,000 was made. During the year ended December 31, 2013 an additional payment of $1,280 was made. During the year ended December 31, 2014, an additional loan of $572 was made. As of December 31, 2014 the outstanding balance is $65,292. Additionally, the accrued expenses are accruing 7% interest per year. As of December 31, 2014 the Company recorded interest expense and related accrued interest payable of $1,955.

	During the year ended December 31, 2013, the Company's Chief Executive Officer forgave accrued payroll of $30,000 and extended the term of existing debt in exchange for the issuance of Series A convertible Preferred Stock ("Series A PS"). In connection with this transaction, the Company incurred a loss on settlement of debt of $5,187,800 (See Note 6(H)).

	As of December 31, 2014, the Company owes $769,420 in accrued salary to principal stockholder. On November 10, 2010, the Company entered into an addendum to the employment agreement, effective January 1, 2011 through the December 31, 2015. The term of the agreement is a five year period at an annual salary of $210,000. There is a 6% annual increase. For the year ending December 31, 2014 the annual salary is $265,120. The employee is also to receive a 20% bonus based on the annual based salary. Any stock, stock options bonuses have to be approved by the board of directors.

	On February 25, 2013, the Company received $150,000 from a principal stockholder. Pursuant to the terms of the loan, the advance bears interest at 3%, is unsecured and due on demand. At December 31, 2013 the Company recorded interest expense and related accrued interest payable of $2,001 and the loan balance of $150,000 was repaid.

	On November 10, 2014, the Company sold to the officer of the Company a used automobile for the price of $14,504. The Company reduced the accrued salary by the purchase price of the vehicle and recorded a gain on the sale of the asset of $8,956.

	As of December 31, 2014 and December 31, 2013, there was $86,325 and $97,138, respectively, included in accounts payable and accrued expenses - related party, which is owed to the Company’s Chief Executive Officer.

	As of December 31, 2014, there was $326,467 of accrued interest- related party and $10,760 in shareholder loan interest – related party included in accounts payable and accrued expenses – related party, which his owed to the Company’s Chief Executive officer.

	As of December 31, 2013, there was $259,796 of accrued interest- related party and $8,310 in shareholder loan interest – related party included in accounts payable and accrued expenses – related party, which his owed to the Company’s Chief Executive officer.

9_SUBSEQUENT_EVENTS

9. SUBSEQUENT EVENTS	12 Months Ended
9. SUBSEQUENT EVENTS	Dec. 31, 2014
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	On January 23, 2015, the board of directors of Kraig Biocraft Laboratories, Inc appointed Mr. Jonathan R. Rice as its Chief Operating Officer. The Employment Agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the Employment Agreement, Mr. Rice is entitled to an annual cash compensation of $120,000, which includes salary, health insurance, 401K retirement plan contributions, etc. The Company also agreed to reimburse Mr. Rice for his past educational expenses of approximately $11,000. In addition, Mr. Rice will be issued a three-year warrant to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.001 per share pursuant to the Employment Agreement.

	On January 21, 2015, the Company issued 2,918,919 shares in connection with the cashless exercise of the 3,000,000 warrants.

	On March 5, 2015, the Company issued 10,000 shares with a fair value of $484 ($0.0321/share) to a consultant as consideration for consulting fees owed from October 1, 2014 through February 28, 2015 of $10,000. The issuance of shares resulted in gain on settlement of accounts payable of $9,679.

	On February 25, 2015, the Company renewed its lease of a Laboratory. The lease is on a month to month basis at an annual rate of $13,200.

1_SUMMARY_OF_SIGNIFICANT_ACCOU1

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Policies)	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
(A) Organization	(A) Organization

	Kraig Biocraft Laboratories, Inc. (the "Company") was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries.
(B) Use of Estimates	(B) Use of Estimates

	In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.
(C) Cash	(C) Cash

	For purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of December 31, 2014 or December 31, 2013.
(D) Loss Per Share	(D) Loss Per Share

	Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by FASB Accounting Standards Codification No. 260, “Earnings per Share.” As of December 31, 2014 and 2013, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive.

	The computation of basic and diluted loss per share at December 31, 2014 and December 31, 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

			December 31,		December 31,
			2014		2013

	Stock Warrants (Exercise price - $0.001/share)			18,000,000		18,000,000
	Convertible Preferred Stock			2		2
	Total			18,000,002		18,000,002
(E) Research and Development Costs	(E) Research and Development Costs

	The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation.
(F) Income Taxes	(F) Income Taxes

	The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

	The net deferred tax liability in the accompanying balance sheets includes the following amounts of deferred tax assets and liabilities:

				2014		2013

	Expected income tax recovery (expense) at the statutory rate of 34%		$	-636,816	$	(2,539,012)
	Tax effect of expenses that are not deductible for income tax purposes (net of other amounts deductible for tax purposes)			222,901		2,153,127
	Change in valuation allowance			413,915		385,583

	Provision for income taxes		$	-	$	-

	The components of deferred income taxes are as follows:

				Years Ended December,
				2014		2013

	Deferred tax liability:		$	-	$	-
	Deferred tax asset
	Net Operating Loss Carryforward			2,829,510		2,415,595
	Valuation allowance			-2,829,510		-2,415,595
	Net deferred tax asset			-		-
	Net deferred tax liability		$	-	$	-

	The valuation allowance was established to reduce the deferred tax asset to the amount that will more likely than not be realized. This is necessary due to the Company’s continued operating losses and the uncertainty of the Company’s ability to utilize all of the net operating loss carryforwards before they will expire through the year 2034.

	The net change in the valuation allowance for the year ended December 31, 2014 and 2013 was an increase of $413,915 and $385,853, respectively.

	Effective January 1, 2009, the Company adopted guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the financial statements and applies to all federal or state income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. As of December 31, 2014 and 2013 there were no amounts that had been accrued in respect to uncertain tax positions.

	None of the Company’s federal or state income tax returns is currently under examination by the Internal Revenue Service (“IRS”) or state authorities. However, fiscal years 2009 and later remain subject to examination by the IRS and respective states.
(G) Derivative Financial Instruments	(G) Derivative Financial Instruments

	Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.

	Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. In addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model.
(H) Stock-Based Compensation	(H) Stock-Based Compensation

	In December 2004, the FASB issued FASB Accounting Standards Codification No. 718, Compensation – Stock Compensation. Under FASB Accounting Standards Codification No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant. The Company applies this statement prospectively.

	Equity instruments (“instruments”) issued to other than employees are recorded on the basis of the fair value of the instruments, as required by FASB Accounting Standards Codification No. 718. FASB Accounting Standards Codification No. 505, Equity Based Payments to Non-Employees defines the measurement date and recognition period for such instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.
(I) Business Segments	(I) Business Segments

	The Company operates in one segment and therefore segment information is not presented.
(J) Recent Accounting Pronouncements	(J) Recent Accounting Pronouncements

	On November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-16—Derivatives and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity (a consensus of the FASB Emerging Issues Task Force). The amendments in this Update do not change the current criteria in GAAP for determining when separation of certain embedded derivative features in a hybrid financial instrument is required. That is, an entity will continue to evaluate whether the economic characteristics and risks of the embedded derivative feature are clearly and closely related to those of the host contract, among other relevant criteria. The amendments clarify how current GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. The effects of initially adopting the amendments in this Update should be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of a share as of the beginning of the fiscal year for which the amendments are effective. Retrospective application is permitted to all relevant prior periods.

	On November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-17—Business Combinations (Topic 805): Pushdown Accounting (a consensus of the FASB Emerging Issues Task Force). The amendments in this Update provide an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. The amendments in this Update are effective on November 18, 2014. After the effective date, an acquired entity can make an election to apply the guidance to future change-in-control events or to its most recent change-in-control event. However, if the financial statements for the period in which the most recent change-in-control event occurred already have been issued

	On June 10, 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation ("ASUE 2014-10"). The guidance is intended to reduce the overall cost and complexity associated with financial reporting for development stage entities without reducing the availability of relevant information. The Board also believes the changes will simplify the consolidation accounting guidance by removing the differential accounting requirements for development stage entities. As a result of these changes, there no longer will be any accounting or reporting differences in GAAP between development stage entities and other operating entities. For organizations defined as public business entities the presentation and disclosure requirements in Topic 915 will no longer be required starting with the first annual period beginning after December 15, 2014, including interim periods therein. Early application is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued (public business entities) or made available for issuance (other entities). The Company adopted this pronouncement for the period from April 25, 2006 (inception) through December 31, 2014.

	In June 2014, FASB issued Accounting Standards Update (“ASU”) No. 2014-12, “Compensation – Stock Compensation (Topic 718); Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period”. The amendments in this ASU apply to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. For all entities, the amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. Entities may apply the amendments in this ASU either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. If retrospective transition is adopted, the cumulative effect of applying this Update as of the beginning of the earliest annual period presented in the financial statements should be recognized as an adjustment to the opening retained earnings balance at that date. Additionally, if retrospective transition is adopted, an entity may use hindsight in measuring and recognizing the compensation cost. This updated guidance is not expected to have a material impact on our results of operations, cash flows or financial condition. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition

	On August 2014, the FASB issued Accounting Standards Update “ASU” 2014-15 on “Presentation of Financial Statements Going Concern (Subtopic 205-40) - Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this Update provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this Update are effective for public and nonpublic entities for annual periods ending after December 15, 2016. Early adoption is permitted. As of December 31, 2014, we have adopted the provisions of this ASU.

	In July 2013, FASB issued ASU No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists." The provisions of ASU No. 2013-11 require an entity to present an unrecognized tax benefit, or portion thereof, in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward, with certain exceptions related to availability. ASU No. 2013-11 is effective for interim and annual reporting periods beginning after December 15, 2013. The adoption of ASU No. 2013-11 is not expected to have a material impact on the Company's Consolidated Financial Statements.

	In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into net income. The amendments in the ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial statements under U.S. GAAP. The new amendments will require an organization to:

	-	Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and
	-	Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.

	The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). The amendments are effective for reporting periods beginning after December 15, 2012, for public companies. Early adoption is permitted. The adoption of ASU No. 2013-02 is not expected to have a material impact on our financial position or results of operations.

	In January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like ASU 2011-11, the amendments in this update will be effective for fiscal periods beginning on, or after January 1, 2013. The adoption of ASU 2013-01 is not expected to have a material impact on our financial position or results of operations.

	All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable
(K) Reclassification	(K) Reclassification

	The 2013 financial statements have been reclassified to conform to the 2014 presentation.
(L) Equipment	(L) Equipment

	The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. The Company uses a five year life for automobiles.

	In accordance with FASB Accounting Standards Codification No. 360, Property, Plant and Equipment, the Company carries long-lived assets at the lower of the carrying amount or fair value. Impairment is evaluated by estimating future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected undiscounted future cash flow is less than the carrying amount of the assets, an impairment loss is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.

	There were no impairment losses recorded during the years ended December 31, 2014 and 2013.
(M) Fair Value of Financial Instruments	(M) Fair Value of Financial Instruments

	We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” (“ASC Topic 820-10”). ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Level 1 instruments include cash, account receivable, prepaid expenses, inventory and account payable and accrued liabilities. The carrying values are assumed to approximate the fair value due to the short term nature of the instrument.

	The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:

	°	Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at December 31, 2014 and December 31, 2013.

	°	Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

	°	Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms.

			December 31,		December 31,
			2014		2013
	Level 1		$	-	$	-
	Level 2			-		-
	Level 3			-		-
	Total		$	-	$	-

1_SUMMARY_OF_SIGNIFICANT_ACCOU2

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Tables)	12 Months Ended
	Dec. 31, 2014
Summary Of Significant Accounting Policies And Organization Tables
Antidilutive Securities Excluded from Computation of Earnings Per Share		December 31,		December 31,
		2014		2013

	Stock Warrants (Exercise price - $0.001/share)		18,000,000		18,000,000
	Convertible Preferred Stock		2		2
	Total		18,000,002		18,000,002
Schedule of income taxes			2014		2013

	Expected income tax recovery (expense) at the statutory rate of 34%	$	-636,816	$	(2,539,012)
	Tax effect of expenses that are not deductible for income tax purposes (net of other amounts deductible for tax purposes)		222,901		2,153,127
	Change in valuation allowance		413,915		385,583

	Provision for income taxes	$	-	$	-
Schedule of deferred income taxes			Years Ended December,
			2014		2013

	Deferred tax liability:	$	-	$	-
	Deferred tax asset
	Net Operating Loss Carryforward		2,829,510		2,415,595
	Valuation allowance		-2,829,510		-2,415,595
	Net deferred tax asset		-		-
	Net deferred tax liability	$	-	$	-
Schedule of fair Value of Financial Instruments		December 31,		December 31,
		2014		2013
	Level 1	$	-	$	-
	Level 2		-		-
	Level 3		-		-
	Total	$	-	$	-

3_EQUIPMENT_Tables

3. EQUIPMENT (Tables)	12 Months Ended
3. EQUIPMENT (Tables)	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Equipment		As of			As of
		December 31,			December 31,
		2014			2013

	Automobile	$	41,805		$	25,828
	Office Equipment		5,560			5,560
	Less Accumulated Depreciation		(4,174	)		(17,295	)

	Total Property and Equipment	$	43,191		$	14,093

6_STOCKHOLDERS_DEFICIT_Tables

6. STOCKHOLDERS' DEFICIT (Tables)	12 Months Ended
6. STOCKHOLDERS' DEFICIT (Tables)	Dec. 31, 2014
Stockholders Deficit Tables
Weighted average assumptions for warrants issued	On November 21, 2012, the Company issued 10-year warrants for 10,000,000 shares with a consultant, with an exercise price of $0.001 per share. The warrants were granted for services rendered. The warrants had a fair value of $400,000, based upon the Black-Scholes option-pricing model. The Company used the following weighted average assumptions:

	Expected dividends			0	%
	Expected volatility			283.23	%
	Expected term		10 years
	Risk free interest rate			1.69	%
	Expected forfeitures			0	%

	On July 18, 2013, the Company issued 9,857,142 shares in connection with the cashless exercise of the 10,000,000 warrants.

	On July 9, 2013, the Company issued 5-year warrants for 10,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services rendered. The warrants had a fair value of $736,816, based upon the Black-Scholes option-pricing model. The Company used the following weighted average assumptions:

	Expected dividends			0	%
	Expected volatility			183.35	%
	Expected term		5 years
	Risk free interest rate			1.5	%
	Expected forfeitures			0	%

	On October 15, 2013, the Company issued 1-year warrants for 8,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $396,083, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon and will be exercisable beginning October 15, 2015 for a period of 12 months.

			Grant Date
	Expected dividends			0	%
	Expected volatility			96.35	%

	Expected term		3 years
	Risk free interest rate			1.45	%
	Expected forfeitures			0	%

	On February 17, 2014, the Company issued 1-year warrants for 600,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $33,620, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon and will be exercisable beginning on the 14 th month anniversary of the agreement and for a period of twelve months thereafter.

			Grant Date
	Expected dividends			0	%
	Expected volatility			86.94	%

	Expected term		2 years
	Risk free interest rate			1.53	%
	Expected forfeitures			0	%

	On February 17, 2014, the Company issued 1-year warrants for 600,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $33,620, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 14 th month anniversary of the agreement and for a period of twelve months thereafter.

			Grant Date
	Expected dividends			0	%
	Expected volatility			86.94	%

	Expected term		2 years
	Risk free interest rate			1.53	%


	On February 17, 2014, the Company issued 1-year warrants for 1,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $56,040, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 20 th month anniversary of the agreement and for a period of twelve months thereafter.

			Grant Date
	Expected dividends			0	%
	Expected volatility			86.23	%

	Expected term		3 years
	Risk free interest rate			1.53	%
	Expected forfeitures			0	%

	On February 17, 2014, the Company issued 1-year warrants for 1,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $56,040, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 20 th month anniversary of the agreement and for a period of twelve months thereafter.

			Grant Date
	Expected dividends			0	%
	Expected volatility			86.23	%

Expected term		3 years
Risk free interest rate			1.53	%
Expected forfeitures			0	%

On February 17, 2014, the Company issued 1-year warrants for 2,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $112,110, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 32nd month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			123.49	%

Expected term		3 years
Risk free interest rate			1.53	%
Expected forfeitures			0	%

On February 17, 2014, the Company issued 1-year warrants for 2,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $112,110, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 32nd month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			123.49	%

Expected term		3 years
Risk free interest rate			1.53	%
Expected forfeitures			0	%

On June 4, 2014, the Company issued 3-year warrant for 3,000,000 shares to a consultant, with an exercise price of $0.001 per share. The warrants were granted for services to be rendered. The warrants had a fair value of $171,102, based upon the Black-Scholes option-pricing model on the date of grant and were fully vested upon issuance and will be exercisable beginning on the 32nd month anniversary of the agreement and for a period of twelve months thereafter.

		Grant Date
Expected dividends			0	%
Expected volatility			86.69	%

Expected term		3 years
Risk free interest rate			0.85	%
Expected forfeitures			0	%
Summary of warrants outstanding			Number of				Weighted Average				Weighted Average Remaining
			Warrants				Exercise Price				Contractual Life
											(in Years)



	Balance, December 31, 2013			18,000,000			$	0.001			2.9
	Granted			10,200,000			$	0.001
	Exercised			(10,000,000	)		$	-
	Cancelled/Forfeited			-
	Balance, September 30, 2014 December 31, 2014			18,200,000			$	0.001				2.1

	Intrinsic Value		$	801,900


	For the year ended December 31, 2014, the following warrants were outstanding:

	Exercise Price				Warrants				Warrants				Weighted Average		Aggregate
	Exercise Price				Outstanding				Exercisable				Remaining Contractual Life		Intrinsic Value

	$	0.001				18,200,000				-				2.1		801,900


	For the year ended December 31, 2013, the following warrants were outstanding:

	Exercise Price				Warrants				Warrants				Weighted Average		Aggregate
	Exercise Price				Outstanding				Exercisable				Remaining Contractual Life		Intrinsic Value

	$	0.001				28,000,000				18,000,000				2.9		918,000
Forgiveness of debt & Issuance of Convertible Preferred Stock			Series A
			PS Valuation
	Debt converted – related party		$	(30,000	)
	Valuation of Series A PS issued as consideration			5,217,800
	Loss on settlement of debt		$	5,187,800

1_SUMMARY_OF_SIGNIFICANT_ACCOU3

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Antidilutive Securities, Stock Warrants (Exercise price - $0.001/share)	18,000,002	18,000,002
Stock Warrants
Antidilutive Securities, Stock Warrants (Exercise price - $0.001/share)	18,000,000	18,000,000
Convertible Preferred Stock
Antidilutive Securities, Stock Warrants (Exercise price - $0.001/share)	2	2

1_SUMMARY_OF_SIGNIFICANT_ACCOU4

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies And Organization Tables
Expected income tax recovery (expense) at the statutory rate of 34%	($636,816)	($2,539,012)
Tax effect of expenses that are not deductible for income tax purposes (net of other amounts deductible for tax purposes)	222,901	2,153,127
Change in valuation allowance	413,915	385,583
Provision for income taxes	$0	$0

1_SUMMARY_OF_SIGNIFICANT_ACCOU5

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies And Organization Details 2
Deferred tax liability:
Deferred tax asset
Net Operating Loss Carryforward	2,829,510	2,415,595
Valuation allowance	-2,829,510	-2,415,595
Net deferred tax asset
Net deferred tax liability

1_SUMMARY_OF_SIGNIFICANT_ACCOU6

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details 3) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Fair value of assets	$0	$0
Level 3 [Member]
Fair value of assets	0	0
Level 1 [Member]
Fair value of assets	0	0
Level 2 [Member]
Fair value of assets	$0	$0

1_SUMMARY_OF_SIGNIFICANT_ACCOU7

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies And Organization Details Narrative
Net change in the valuation allowance for deferred tax asset	$413,915	$385,853
Impairment losses	$0	$0

2_GOING_CONCERN_Details_Narrat

2. GOING CONCERN (Details Narrative) (USD $)	12 Months Ended
2. GOING CONCERN (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Going Concern Details Narrative
Working capital deficiency	$1,268,873
Stockholders Deficit	1,225,682	1,201,402	1,134,416
Net Cash Used In Operating Activities	$904,559	$800,154

3_EQUIPMENT_Details

3. EQUIPMENT (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Equipment Details
Automobile	$41,805	$25,828
Office Equipment	5,560	5,560
Less Accumulated Depreciation	-4,174	-17,295
Total Property and Equipment	$43,191	$14,093

3_EQUIPMENT_Details_Narrative

3. EQUIPMENT (Details Narrative) (USD $)	12 Months Ended
3. EQUIPMENT (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Equipment Details Narrative
Depreciation and amortization expense	$7,159	$5,888

4_LOAN_PAYABLE_Details_Narrati

4. LOAN PAYABLE (Details Narrative) (USD $)	12 Months Ended
4. LOAN PAYABLE (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Debt Disclosure [Abstract]
Repayments of loan payable	$3,981	$4,774

6_STOCKHOLDERS_DEFICIT_Details

6. STOCKHOLDERS' DEFICIT (Details)	12 Months Ended
6. STOCKHOLDERS' DEFICIT (Details)	Dec. 31, 2014
On November 21, 2012 [Member] \| Warrant [Member]
Expected dividends	0.00%
Expected volatility	283.23%
Expected term	10 years
Risk free interest rate	1.69%
Expected forfeitures	0.00%
On July 9, 2013 [Member] \| Warrant 1 [Member]
Expected dividends	0.00%
Expected volatility	183.35%
Expected term	5 years
Risk free interest rate	1.50%
Expected forfeitures	0.00%
On October 15, 2013 [Member] \| Warrant 2 [Member]
Expected dividends	0.00%
Expected volatility	96.35%
Expected term	3 years
Risk free interest rate	1.45%
Expected forfeitures	0.00%
On February 17, 2014 [Member] \| Warrant 3 [Member]
Expected dividends	0.00%
Expected volatility	86.94%
Expected term	2 years
Risk free interest rate	1.53%
Expected forfeitures	0.00%
On February 17, 2014 [Member] \| Warrant 4 [Member]
Expected dividends	0.00%
Expected volatility	86.94%
Expected term	2 years
Risk free interest rate	1.53%
Expected forfeitures	0.00%
On February 17, 2014 [Member] \| Warrant 5 [Member]
Expected dividends	0.00%
Expected volatility	86.23%
Expected term	3 years
Risk free interest rate	1.53%
Expected forfeitures	0.00%
On February 17, 2014 [Member] \| Warrant 6 [Member]
Expected dividends	0.00%
Expected volatility	86.23%
Expected term	3 years
Risk free interest rate	1.53%
Expected forfeitures	0.00%
On February 17, 2014 [Member] \| Warrant 7 [Member]
Expected dividends	0.00%
Expected volatility	123.49%
Expected term	3 years
Risk free interest rate	1.53%
Expected forfeitures	0.00%
On February 17, 2014 [Member] \| Warrant 8 [Member]
Expected dividends	0.00%
Expected volatility	123.49%
Expected term	3 years
Risk free interest rate	1.53%
Expected forfeitures	0.00%
On June 4, 2014 [Member] \| Warrant 9 [Member]
Expected dividends	0.00%
Expected volatility	86.69%
Expected term	3 years
Risk free interest rate	0.85%
Expected forfeitures	0.00%

6_STOCKHOLDERS_DEFICIT_Details1

6. STOCKHOLDERS' DEFICIT (Details 1) (USD $)	12 Months Ended
6. STOCKHOLDERS' DEFICIT (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Stockholders Deficit Tables
Number of Warrants Outstanding, Beginning	18,000,000
Number of Warrants Granted	10,200,000	10,000,000
Number of Warrants Exercised	-10,000,000	-10,000,000
Number of Warrants Cancelled/Forfeited
Number of Warrants Outstanding, Ending	18,200,000	18,000,000
Weighted Average Exercise Price Outstanding, Beginning	$0.00
Weighted Average Exercise Price Granted	$0.00
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Outstanding, Ending	$0.00	$0.00
Weighted Average Remaining Contractual Life (in years) Outstanding	2 years 1 month 6 days	2 years 10 months 24 days
Aggregate Intrinsic Value	$801,900	$918,000

6_STOCKHOLDERS_DEFICIT_Details2

6. STOCKHOLDERS' DEFICIT (Details 2) (USD $)	12 Months Ended
6. STOCKHOLDERS' DEFICIT (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Equity [Abstract]
Exercise Price	$0.00	$0.00
Warrants Outstanding	18,200,000	18,000,000
Warrants Exercisable		18,000,000
Weighted Average Remaining Contractual Life	2 years 1 month 6 days	2 years 10 months 24 days
Aggregate Intrinsic Value	$801,900	$918,000

6_STOCKHOLDERS_DEFICIT_Details3

6. STOCKHOLDERS' DEFICIT (Details 3) (USD $)	12 Months Ended
6. STOCKHOLDERS' DEFICIT (Details 3) (USD $)	Dec. 31, 2014
Stockholders Deficit Tables
Debt converted - related party	($30,000)
Valuation of Series A PS issued as consideration	5,217,800
Loss on settlement of debt	$5,187,800

7_COMMITMENTS_AND_CONTINGENCIE1

7. COMMITMENTS AND CONTINGENCIES (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Commitments And Contingencies Details Narrative
Loan outstanding balance	$65,292
Research and Development	439,536	489,434
Rent expense	14,137	13,565
Interest expense and related accrued interest payable	1,954
Additional payment		1,280
Additional loan	$572

8_RELATED_PARTY_TRANSACTIONS_D

8. RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	12 Months Ended
8. RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Loan outstanding balance	$65,292
Interest expense related party	1,955
Officers compensation	318,144	237,134
Repayment of debt	0	150,000
Accounts payable and accrued expenses - related party	86,325	97,138
Accrued interest- related party	326,467	259,796
Additional payment		1,280
Additional loan	572
Principal stockholder
Amount due to related party	769,420
Interest expense related party		2,001
Repayment of debt		150,000
Accrued interest- related party	10,760	8,310
Officer
Amount due to related party	65,292
Officers compensation	$265,120